Yes, immune profiling can help predict how a patient will respond to certain treatments. For example, the presence of a high number of tumor-infiltrating lymphocytes (TILs) often correlates with a better response to immunotherapy. Similarly, the expression levels of specific genes or proteins involved in immune evasion can indicate the likelihood of success with particular immunotherapeutic agents.
